Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites

Molecular and Cellular Biology

Volumn 32, Issue 19, 2012, Pages 3802-3813

  Hyde, Caroline A C ^a   Giese, Alexandra ^a   Stuttfeld, Edward ^a,c   Saliba, Johan Abram ^b   Villemagne, Denis ^b   Schleier, Thomas ^a   Binz, H Kaspar ^b   Ballmer Hofer, Kurt ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b MOLECULAR PARTNERS AG   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; IMMUNOGLOBULIN D; VASCULOTROPIN RECEPTOR 2;

ALLOSTERISM; ARTICLE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; AMINO ACID SEQUENCE; ANIMALS; GENE EXPRESSION; HUMANS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84868699474     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06787-11     Document Type: Article

References (32)

1. Arefieva TI, Kukhtina NB, Antonova OA, Krasnikova TL. 2005. MCP-1-stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades. Cytokine 31:439-446.
2. Aricescu AR, Lu W, Jones EY. 2006. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D Biol. Crystallogr. 62:1243-1250.
3. Barleon B, et al. 1997. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem. 272:10382-10388.
4. Bellou S, et al. 2009. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. Am. J. Physiol. Cell Physiol. 297:C1477-C1489.
5. Binz HK, et al. 2004. High-affinity binders selected from designed ankyrin repeat protein libraries. Nat. Biotechnol. 22:575-582.
6. Brozzo MS, et al. 2012. Thermodynamic and structural description of allosterically regulated VEGF receptor 2 dimerization. Blood 119:1781-1788.
7. Dell'Era Dosch D, Ballmer-Hofer K. 2010. Transmembrane domainmediated orientation of receptor monomers in active VEGFR-2 dimers. FASEB J. 24:32-38.
8. Eriksson A, et al. 2003. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 107:1532-1538. 8a
9. Franklin MC, et al. 2004. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5:317-328.
10. Fuh G, Li B, Crowley C, Cunningham B, Wells JA. 1998. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J. Biol. Chem. 273:11197-11204.
11. Geiser M, Cébe R, Drewello D, Schmitz R. 2001. Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. Biotechniques 31:88-90, 92.
12. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
13. Heinzel SS, Krysan PJ, Calos MP, DuBridge RB. 1988. Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J. Virol. 62:3738-3746.
14. Kendrew J, et al. 2011. An antibody targetted to VEGFR-2 Ig domains 4-7 inhibits VEGFR-2 activation and VEGFR-2 dependent angiogenesis without affecting ligand binding. Mol. Cancer Ther. 10:770-783.
15. Kisko K, et al. 2011. Structural analysis of vascular endothelial growth factor receptor-2/ligand complexes by small-angle X-ray solution scattering. FASEB J. 25:2980-2986.
16. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. 2011. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437:169-183.
17. Korff T, Krauss T, Augustin HG. 2004. Three-dimensional spheroidal culture of cytotrophoblast cells mimics the phenotype and differentiation of cytotrophoblasts from normal and preeclamptic pregnancies. Exp. Cell Res. 297:415-423.
18. Leppänen VM, et al. 2010. Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc. Natl. Acad. Sci. U. S. A. 107:2425-2430.
19. Liang CC, Park AY, Guan JL. 2007. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2:329-333.
20. Liu F, et al. 2001. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am. J. Respir. Cell Mol. Biol. 24:711-719.
21. McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM. 2005. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J. Biol. Chem. 280:20995-21003.
22. Pepper MS, et al. 1992. Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol. 262:C1246-C1257.
23. Ruch C, Skiniotis G, Steinmetz MO, Walz T, Ballmer-Hofer K. 2007. Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Nat. Struct. Mol. Biol. 14:249-250.
24. Ruch C. 2007. Structure/function analysis of the extracellular domain of vascular endothelial growth factor receptor-2 (VEGFR-2). Ph.D. dissertation. ETH, Zurich, Switzerland.
25. Shinkai A, et al. 1998. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domaincontaining receptor for vascular endothelial growth factor. J. Biol. Chem. 273:31283-31288.
26. Stuttfeld E, Ballmer-Hofer K. 2009. Structure and function of VEGF receptors. IUBMB Life 61:915-922.
27. Tao Q, Backer MV, Backer JM, Terman BI. 2001. Kinase insert domain receptor (kdr) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling. J. Biol. Chem. 276:21916-21923.
28. Tvorogov D, et al. 2010. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell 18:630-640.
29. Yang Y, Xie P, Opatowsky Y, Schlessinger J. 2010. Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling. Proc. Natl. Acad. Sci. U. S. A. 107:1906-1911.
30. Yang Y, Yuzawa S, Schlessinger J. 2008. Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization. Proc. Natl. Acad. Sci. U. S. A. 105:7681-7686.
31. Yuzawa S, et al. 2007. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 130:323-334.
32. Zahnd C, Amstutz P, Pluckthun A. 2007. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods 4:269-279.